BL-1827

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBL-1827
Drug Alias NameBL-1827
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsCancer PainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioglan Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioglan Pharma
Active IndicationsN/A
Inactive IndicationsCancer PainPain, Postoperative

Other Information

ATC CodeN/A
Related LinksN/A